Precision BioSciences Inc (DTIL)
9.67
-1.06
(-9.88%)
USD |
NASDAQ |
Apr 19, 16:00
9.67
0.00 (0.00%)
After-Hours: 20:00
Precision BioSciences Cash from Operations (TTM): -84.11M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -84.11M |
| September 30, 2023 | -97.53M |
| June 30, 2023 | -45.26M |
| March 31, 2023 | -48.34M |
| December 31, 2022 | -45.75M |
| September 30, 2022 | -47.59M |
| June 30, 2022 | -100.68M |
| March 31, 2022 | -107.80M |
| December 31, 2021 | -10.85M |
| September 30, 2021 | -0.624M |
| June 30, 2021 | 1.058M |
| Date | Value |
|---|---|
| March 31, 2021 | 6.596M |
| December 31, 2020 | -87.39M |
| September 30, 2020 | -94.49M |
| June 30, 2020 | -86.24M |
| March 31, 2020 | -77.02M |
| December 31, 2019 | -71.02M |
| September 30, 2019 | -63.37M |
| June 30, 2019 | -64.44M |
| March 31, 2019 | -57.18M |
| December 31, 2018 | -51.72M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-107.80M
Minimum
Mar 2022
6.596M
Maximum
Mar 2021
-59.20M
Average
-64.44M
Median
Jun 2019
Cash from Operations (TTM) Benchmarks
| Altimmune Inc | -75.81M |
| BioVie Inc | -41.11M |
| Adial Pharmaceuticals Inc | -6.807M |
| Gritstone Bio Inc | -121.65M |
| Humacyte Inc | -73.30M |